Cargando…

Engineering of CYP76AH15 can improve activity and specificity towards forskolin biosynthesis in yeast

BACKGROUND: Forskolin is a high-value diterpenoid produced exclusively by the Lamiaceae plant Coleus forskohlii. Today forskolin is used pharmaceutically for its adenyl-cyclase activating properties. The limited availability of pure  forskolin is currently hindering its full utilization, thus a new...

Descripción completa

Detalles Bibliográficos
Autores principales: Forman, Victor, Bjerg-Jensen, Niels, Dyekjær, Jane D., Møller, Birger Lindberg, Pateraki, Irini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240942/
https://www.ncbi.nlm.nih.gov/pubmed/30453976
http://dx.doi.org/10.1186/s12934-018-1027-3
_version_ 1783371714877456384
author Forman, Victor
Bjerg-Jensen, Niels
Dyekjær, Jane D.
Møller, Birger Lindberg
Pateraki, Irini
author_facet Forman, Victor
Bjerg-Jensen, Niels
Dyekjær, Jane D.
Møller, Birger Lindberg
Pateraki, Irini
author_sort Forman, Victor
collection PubMed
description BACKGROUND: Forskolin is a high-value diterpenoid produced exclusively by the Lamiaceae plant Coleus forskohlii. Today forskolin is used pharmaceutically for its adenyl-cyclase activating properties. The limited availability of pure  forskolin is currently hindering its full utilization, thus a new environmentally friendly, scalable and sustainable strategy is needed for forskolin production. Recently, the entire biosynthetic pathway leading to forskolin was elucidated. The key steps of the pathway are catalyzed by cytochrome P450 enzymes (CYPs), which have been shown to be the limiting steps of the pathway. Here we study whether protein engineering of the substrate recognition sites (SRSs) of CYPs can improve their efficiency towards forskolin biosynthesis in yeast. RESULTS: As a proof of concept, we engineered the enzyme responsible for the first putative oxygenation step of the forskolin pathway: the conversion of 13R-manoyl oxide to 11-oxo-13R-manoyl oxide, catalyzed by the CYP76AH15. Four CYP76AH15 variants—engineered in the SRS regions—yielded at least a twofold increase of 11-oxo-13R-manoyl oxide when expressed in yeast cells grown in microtiter plates. The highest titers (5.6-fold increase) were observed with the variant A99I, mutated in the SRS1 region. Double or triple CYP76AH15 mutant variants resulted in additional enzymes with optimized performances. Moreover, in planta CYP76AH15 can synthesize ferruginol from miltiradiene. In this work, we showed that the mutants affecting 11-oxo-13R-manoyl oxide synthesis, do not affect ferruginol production, and vice versa. The best performing variant, A99I, was utilized to reconstruct the forskolin biosynthetic pathway in yeast cells. Although these strains showed increased 11-oxo-manoyl oxide production and higher accumulation of other pathway intermediates compared to the native CYP76AH15, lower production of forskolin was observed. CONCLUSIONS: As demonstrated for CYP76AH15, site-directed mutagenesis of SRS regions of plant CYPs may be an efficient and targeted approach to increase the performance of these enzymes. Although in this work we have managed to achieve higher efficiency and specificity of the first CYP of the pathway, further work is necessary in order to increase the overall production of forskolin in yeast cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-018-1027-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6240942
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62409422018-11-23 Engineering of CYP76AH15 can improve activity and specificity towards forskolin biosynthesis in yeast Forman, Victor Bjerg-Jensen, Niels Dyekjær, Jane D. Møller, Birger Lindberg Pateraki, Irini Microb Cell Fact Research BACKGROUND: Forskolin is a high-value diterpenoid produced exclusively by the Lamiaceae plant Coleus forskohlii. Today forskolin is used pharmaceutically for its adenyl-cyclase activating properties. The limited availability of pure  forskolin is currently hindering its full utilization, thus a new environmentally friendly, scalable and sustainable strategy is needed for forskolin production. Recently, the entire biosynthetic pathway leading to forskolin was elucidated. The key steps of the pathway are catalyzed by cytochrome P450 enzymes (CYPs), which have been shown to be the limiting steps of the pathway. Here we study whether protein engineering of the substrate recognition sites (SRSs) of CYPs can improve their efficiency towards forskolin biosynthesis in yeast. RESULTS: As a proof of concept, we engineered the enzyme responsible for the first putative oxygenation step of the forskolin pathway: the conversion of 13R-manoyl oxide to 11-oxo-13R-manoyl oxide, catalyzed by the CYP76AH15. Four CYP76AH15 variants—engineered in the SRS regions—yielded at least a twofold increase of 11-oxo-13R-manoyl oxide when expressed in yeast cells grown in microtiter plates. The highest titers (5.6-fold increase) were observed with the variant A99I, mutated in the SRS1 region. Double or triple CYP76AH15 mutant variants resulted in additional enzymes with optimized performances. Moreover, in planta CYP76AH15 can synthesize ferruginol from miltiradiene. In this work, we showed that the mutants affecting 11-oxo-13R-manoyl oxide synthesis, do not affect ferruginol production, and vice versa. The best performing variant, A99I, was utilized to reconstruct the forskolin biosynthetic pathway in yeast cells. Although these strains showed increased 11-oxo-manoyl oxide production and higher accumulation of other pathway intermediates compared to the native CYP76AH15, lower production of forskolin was observed. CONCLUSIONS: As demonstrated for CYP76AH15, site-directed mutagenesis of SRS regions of plant CYPs may be an efficient and targeted approach to increase the performance of these enzymes. Although in this work we have managed to achieve higher efficiency and specificity of the first CYP of the pathway, further work is necessary in order to increase the overall production of forskolin in yeast cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-018-1027-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-19 /pmc/articles/PMC6240942/ /pubmed/30453976 http://dx.doi.org/10.1186/s12934-018-1027-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Forman, Victor
Bjerg-Jensen, Niels
Dyekjær, Jane D.
Møller, Birger Lindberg
Pateraki, Irini
Engineering of CYP76AH15 can improve activity and specificity towards forskolin biosynthesis in yeast
title Engineering of CYP76AH15 can improve activity and specificity towards forskolin biosynthesis in yeast
title_full Engineering of CYP76AH15 can improve activity and specificity towards forskolin biosynthesis in yeast
title_fullStr Engineering of CYP76AH15 can improve activity and specificity towards forskolin biosynthesis in yeast
title_full_unstemmed Engineering of CYP76AH15 can improve activity and specificity towards forskolin biosynthesis in yeast
title_short Engineering of CYP76AH15 can improve activity and specificity towards forskolin biosynthesis in yeast
title_sort engineering of cyp76ah15 can improve activity and specificity towards forskolin biosynthesis in yeast
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240942/
https://www.ncbi.nlm.nih.gov/pubmed/30453976
http://dx.doi.org/10.1186/s12934-018-1027-3
work_keys_str_mv AT formanvictor engineeringofcyp76ah15canimproveactivityandspecificitytowardsforskolinbiosynthesisinyeast
AT bjergjensenniels engineeringofcyp76ah15canimproveactivityandspecificitytowardsforskolinbiosynthesisinyeast
AT dyekjærjaned engineeringofcyp76ah15canimproveactivityandspecificitytowardsforskolinbiosynthesisinyeast
AT møllerbirgerlindberg engineeringofcyp76ah15canimproveactivityandspecificitytowardsforskolinbiosynthesisinyeast
AT paterakiirini engineeringofcyp76ah15canimproveactivityandspecificitytowardsforskolinbiosynthesisinyeast